
Please try another search
InhaleRx Limited, a biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia. It is developing IRX-211 that has completed Phase 1 clinical trial for the treatment of Breakthrough Cancer Pain (BTcP); and IRX-616a that is in preclinical trial for panic disorder (PD). The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is headquartered in Melbourne, Australia.
Name | Age | Since | Title |
---|---|---|---|
Sean Williams | - | 2021 | Non-Executive Chairman |
Antony FitzGerald | - | 2025 | Non-Executive Director |
Ronald Walter Wise | 83 | 2024 | Non-Executive Director |
Megan Ritchie | - | 2025 | Member of Scientific Advisory Board |
Meera Agar | - | 2025 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review